openPR Logo
Press release

Alzheimer’s Drugs Market to Rise at an Impressive CAGR

01-22-2020 10:48 AM CET | Health & Medicine

Press release from: Fortune Business Insights Private Limited

Alzheimer’s Drugs Market

Alzheimer’s Drugs Market

Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market, says Fortune Business Insights in a report, titled “Alzheimer’s Drugs Market Size, Share and Global Trend By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Antagonist, Combination Drugs, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2026.” Rising R&D activities by pharmaceutical companies and research institutes for Alzheimer effective therapy is expected to boost the global Alzheimer’s drugs market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/alzheimers-drugs-market-101033

Highlights of the Report:

• In-depth analysis of various insights, namely, Alzheimer’s Drugs Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Alzheimer’s Drugs Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Key Players Operating in The Alzheimer’s Drugs Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Pfizer Inc.
• Eli Lilly and Company.
• Merck Sharp & Dohme Corp.
• AstraZeneca
• Biogen
• AbbVie Inc.
• ALLERGAN

Increasing R&D Investments by Pharmaceutical Companies Will Propel Growth

The active study of Alzheimer’s drug by pharmaceutical industries and research institutes for creating a strong pipeline for effective therapy is predicted to encourage growth of the global Alzheimer’s drugs market. According to the World Health Organization (WHO) currently, 50 million people are affected by dementia, and the number is expected to increase during the forecast period. In addition, the increasing cases of Alzheimer’s disease around the world have led towards high demand for Alzheimer’s drugs, which in turn is boosting the global Alzheimer’s drugs growth. However, discontinuation of clinical trials for Alzheimer’s drugs by leading pharmaceutical companies which is resulting in limited treatment options and thus creating a global economic burden by increasing the nation’s annual treatment cost against Alzheimer’s drugs development and disease treatment. This factor is predicted to hamper the growth of the global Alzheimer’s drugs market during the forecast period. For instance, Eisai and Biogen, Co., Ltd., declared the termination of phase 3 clinical trial of ENGAGE and EMERGE designed to evaluate the safety and efficacy in the treatment of Alzheimer’s disease.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/alzheimers-drugs-market-101033

Collaboration Between Eli Lilly and AC Immune Will Aid Growth

Eli Lilly and Company and AC Immune SA announced their partnership agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease (AD) and other neurodegenerative diseases. The collaboration between the two companies is predicted to benefit Alzheimer’s drugs revenue owing to the Morphomer™ platform technology which will offer commercial capabilities in central nervous system disorders along with AC Immune's lead molecule, ACI-3024. Furthermore, the development of digital tools for Alzheimer’s disease and dementia is also expected to contribute to the global Alzheimer’s drugs growth. For instance, the Alzheimer's Drug Discovery Foundation (ADDF), announced a new initiative -Diagnostics Accelerator program that aims to track the development of digital tools for Alzheimer’s disease and dementia.

Global Alzheimer’s Drugs Market Segmentation

By Drug Class
• Cholinesterase Inhibitors
• N-Methyl-D-Aspartate (NMDA) Antagonist
• Combination Drugs
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Application
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/alzheimers-drugs-market-101033

Report Focus:

• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential Alzheimer’s Drugs Market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Reasons to Purchase this Report:

• Comprehensive analysis of the Alzheimer’s Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Related Reports:

Orthopedic Joint Replacement Market Size, Outlook 2020 | North America, Europe & Asia Pacific Regions to Project Over the Global Industry- https://www.medgadget.com/2020/01/orthopedic-joint-replacement-market-size-outlook-2020-north-america-europe-asia-pacific-regions-to-project-over-the-global-industry.html

Knee Replacement Market Global Size, Share 2020 | North America, Europe & Asia Pacific Regions to Dominate the Global Industry- https://www.medgadget.com/2020/01/knee-replacement-market-global-size-share-2020-north-america-europe-asia-pacific-regions-to-dominate-the-global-industry.html

How Worldwide Trends are Creating Waves in the Adalimumab Biosimilar Market in 2020- https://www.medgadget.com/2020/01/how-worldwide-trends-are-creating-waves-in-the-adalimumab-biosimilar-market-in-2020.html

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Drugs Market to Rise at an Impressive CAGR here

News-ID: 1903901 • Views: 417

More Releases from Fortune Business Insights Private Limited

Surgical Stapling Devices Market 2026 Global Industry Size, Growth Factor, Sales …
The rising prevalence of chronic diseases is expected to contribute positively to the surgical stapling devices market, says Fortune Business Insights in a report, titled "Surgical Stapling Devices Market Size, Share & Industry Analysis, By Product Type (Powered, Manual), By Type (Disposable, Re-usable), By Application (Gynecology Surgery, Urology Surgery, General Surgery, Others), By Surgery Type (Open Surgery, Laparoscopic Surgery), By End-user (Hospitals, Speciality Clinics, Others) and Regional Forecast, 2019-2026." The
Knee Replacement Market 2026 Share. Size, Growth Factor, Trends and Top Key Comp …
The global "Knee Replacement" Market will derive growth from recent advancements in the material associated with the surgical procedures. According to a report published by Fortune Business Insights, titled "Knee Replacement Market Size, Share & Industry Analysis, By Procedure (Total Knee Arthroplasty, Partial Knee Arthroplasty, and Revision Arthroplasty) By Implant Type (Fixed Bearing, Mobile Bearing, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres, and Others) and Regional Forecast, 2019-2026,"
Breast Implants Market 2020 Global Size, Share, Trends, Future Growth and Top ke …
Rising desire to look attractive and fit among women augments demand for breast implants procedures. As per the report, the global breast implants market was worth US$ USD 2.6 Billion in 2018 and is anticipated to reach USD 4.3 Billion by 2026. The market is likely to expand a CAGR of 6.7% between 2018 and 2026. As per a study by the International Society of Aesthetic Plastic Surgery, breast augmentation
Veterinary Diagnostics Market 2020 Global Size, Share and Top Key Players- Rando …
The Global Veterinary Diagnostics Market is likely to expand in the coming years, according to a report published by Fortune Business Insights, titled "Veterinary Diagnostics Market Size, Share and Global Trend By Animal Type (Livestock, Companion), By Product (Instruments, Consumables), By Modality (Molecular Diagnostics, Diagnostic Imaging, Hematology Analyzers, Immunodiagnostic Tests,Clinical Biochemistry), By End User (Veterinary Hospitals, Veterinary Clinics) and Geography Forecast till 2026". For more information in the analysis of

All 5 Releases


More Releases for Alzheimer

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growt …
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently
Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as